FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

864011003: Cabozantinib s-malate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3951852016 Cabozantinib s-malate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3951853014 Cabozantinib s-malate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabozantinib s-malate Is a Enzyme inhibitor false Inferred relationship Some
Cabozantinib s-malate Is a Pyridine true Inferred relationship Some
Cabozantinib s-malate Is a Quinoline true Inferred relationship Some
Cabozantinib s-malate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Cabozantinib s-malate Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Cabozantinib s-malate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Cabozantinib (substance) true Inferred relationship Some
Cabozantinib s-malate Is a Antineoplastic agent (substance) true Inferred relationship Some
Cabozantinib s-malate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Vascular endothelial growth factor receptor antagonist (disposition) true Inferred relationship Some
Cabozantinib s-malate Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1
Product containing precisely cabozantinib (as cabozantinib s-malate) 80 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start